Publication Type

Journal Article

Version

publishedVersion

Publication Date

8-2025

Abstract

This study examined how direct experiences with COVID-19 infection and vaccination and indirect experience through government and media information predict individuals' intention to receive a COVID-19 booster dose. Drawing on secondary risk theory, we conducted a nationally representative door-to-door survey of 1000 adult Singapore residents in mid-2024. We used structural equation modeling to test whether risk perceptions and efficacy beliefs mediate the effects of experience and information exposure on booster intention. Booster intention was positively related to perceived susceptibility to infection, vaccine effectiveness, vaccination self-efficacy, and prior vaccination, and negatively related to perceived severity of and susceptibility to booster side effects and prior COVID-19 infection. The model explained 26 % of the variance in booster intention. Prior infection positively predicted perceived susceptibility to infection and negatively predicted perceived vaccine effectiveness. Prior vaccination positively predicted perceived vaccine effectiveness and self-efficacy, and negatively predicted concerns about side effects. Information exposure via the government and television news was positively related to perceived severity of and susceptibility to illness and vaccination self-efficacy. There were three notable mediation effects in the prediction of booster intention. The effect of prior infection was mediated by perceived vaccine effectiveness and the effect of prior vaccination was mediated by perceived vaccine effectiveness and perceived severity of vaccine side effects. These findings suggest that personal vaccination history and beliefs about vaccine effectiveness and safety may be especially important for promoting booster uptake.

Keywords

Booster intention, Risk perception, Secondary risk theory, Direct experience, Health information, Singapore

Discipline

Asian Studies | Public Health

Research Areas

Integrative Research Areas

Publication

Vaccine

Volume

61

First Page

1

Last Page

8

ISSN

0264-410X

Identifier

10.1016/j.vaccine.2025.127435

Publisher

Elsevier

Copyright Owner and License

Authors

Additional URL

https://doi.org/10.1016/j.vaccine.2025.127435

Share

COinS